Aslan Pharmaceuticals Ltd.

05/05/2021 | News release | Distributed by Public on 05/05/2021 03:27

ASLAN Pharmaceuticals To Present Data On ASLAN004 At Society for Investigative Dermatology

ASLAN Pharmaceuticals To Present Data On ASLAN004 At Society for Investigative Dermatology

ASLAN Pharmaceuticals (NASDAQ: ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that an abstract on ASLAN004 has been accepted for poster presentation at the upcoming 2021 Society for Investigative Dermatology (SID) virtual meeting between 3-8 May, 2021. The data is available to view during the Pharmacology and Drug Development segment on 6 May, 2.30pm to 4pm EST, and will be published in the fall edition of the Journal of Investigative Dermatology.

For more information, please refer to the English press release.